Cancer Treatment Reviews
Volume 29, Issue 5 , Pages 431-440, October 2003

Role of quinupristin/dalfopristin in the treatment of Gram-positive nosocomial infections in haematological or oncological patients

  • J Klastersky

      Affiliations

    • Corresponding Author InformationCorrespondence to: J. Klastersky M.D., Professor and Chief of Medicine, Department of Medicine, Institut Jules Bordet, Rue Héger-Bordet 1, 1000 Bruxelles, Belgium. Tel.: +32-25413201; fax: +32-25413202

Department of Medicine, Institut Jules Bordet, Bruxelles, Belgium

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0305-7372(03)00069-0

doi:10.1016/S0305-7372(03)00069-0

Cancer Treatment Reviews
Volume 29, Issue 5 , Pages 431-440, October 2003

Article Tools